DST-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medical and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Institute for Virology and Immunobiology, University of Würzburg, Würzburg, Germany.
EBioMedicine. 2020 Mar;53:102670. doi: 10.1016/j.ebiom.2020.102670. Epub 2020 Feb 26.
Mycobacterium tuberculosis (M.tb) is likely the most successful human pathogen, capable of evading protective host immune responses and driving metabolic changes to support its own survival and growth. Ineffective innate and adaptive immune responses inhibit effective clearance of the bacteria from the human host, resulting in the progression to active TB disease. Many regulatory mechanisms exist to prevent immunopathology, however, chronic infections result in the overproduction of regulatory myeloid cells, like myeloid-derived suppressor cells (MDSC), which actively suppress protective host T lymphocyte responses among other immunosuppressive mechanisms. The mechanisms of M.tb internalization by MDSC and the involvement of host-derived lipid acquisition, have not been fully elucidated. Targeted research aimed at investigating MDSC impact on phagocytic control of M.tb, would be advantageous to our collective anti-TB arsenal. In this review we propose a mechanism by which M.tb may be internalized by MDSC and survive via the manipulation of host-derived lipid sources.
结核分枝杆菌(M.tb)可能是最成功的人类病原体,能够逃避宿主保护性免疫反应,并驱动代谢变化以支持其自身的存活和生长。无效的先天和适应性免疫反应抑制了从人体宿主中有效清除细菌,导致活动性结核病的进展。存在许多调节机制来防止免疫病理学,然而,慢性感染导致调节性髓样细胞(如髓源性抑制细胞(MDSC))的过度产生,其通过其他免疫抑制机制积极抑制保护性宿主 T 淋巴细胞反应。MDSC 内化 M.tb 的机制以及宿主来源的脂质获取的参与尚未完全阐明。针对调查 MDSC 对 M.tb 吞噬控制影响的靶向研究,将有利于我们的集体抗结核武器库。在这篇综述中,我们提出了一种机制,即 M.tb 可能通过 MDSC 内化并通过操纵宿主来源的脂质来源来存活。